Year: 2010
Type: editorial
Abstract: A phase III 5.multi-institutional randomized study of immunization with the gp100:209-217(210M) peptide followed by high-dose IL-2 compared with high-dose IL-2 alone in patients with metastatic melanoma.
Source: New England Journal of Medicine
DOI: 10.1056/nejme1004139
Authors: Amy S. Kelley, Diane E. Meier
Institution: Icahn School of Medicine at Mount Sinai
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2037838623
